.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Colorcon
Healthtrust
US Department of Justice
McKesson
Medtronic
Fuji
Moodys
Dow

Generated: June 28, 2017

DrugPatentWatch Database Preview

Sanofi Aventis Us Company Profile

« Back to Dashboard

Summary for Applicant: Sanofi Aventis Us

Patents:57
Tradenames:113
Ingredients:93
NDAs:136
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
APIDRA
insulin glulisine recombinant
INJECTABLE;IV (INFUSION), SUBCUTANEOUS021629-001Apr 16, 2004RXYesYes7,696,162► SubscribeY ► Subscribe
Sanofi Aventis Us
SLO-BID
theophylline
CAPSULE, EXTENDED RELEASE;ORAL087894-001Jan 31, 1985DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
AZOLID
phenylbutazone
TABLET;ORAL087091-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
CHILDREN'S ALLEGRA HIVES
fexofenadine hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL021909-003Jan 24, 2011OTCYesYes6,037,353► Subscribe ► Subscribe
Sanofi Aventis Us
RIFATER
isoniazid; pyrazinamide; rifampin
TABLET;ORAL050705-001May 31, 1994RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Merck
UBS
McKesson
Deloitte
Baxter
US Army
Julphar
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot